Reply to: “Use of immortal time within survival analysis” - 13/12/18
Funding sources: Supported by Stanford Medical Scholars Research Program (to Mr Lee). Stanford Cancer Institute Research Database (SCIRDB) is funded by a National Cancer Institute Cancer Center support grant (no. 5P30CA124435) and Stanford National Institutes of Health/National Center for Research Resources Clinical and Translational Science Award (no. UL1 RR025744). |
|
Conflicts of interest: Dr Chang is a clinical investigator and advisory board member for Merck and Regeneron. All other authors do not have any conflicts of interested to disclose. |
Vol 80 - N° 1
P. e19-e20 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?